EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CD3 downregulation identifies high-avidity human CD8 T cells

Genevieve T Clutton iD, Ann Marie K Weideman, Melissa A Mischell, Sallay Kallon, Shayla Z Conrad, Fiona R Shaw, Joanna A Warren, Lin Lin, JoAnn D Kuruc, Yinyan Xu, Cynthia M Gay, Paul M Armistead und 2 weitere

Clinical and Experimental Immunology · 2024

DOI: 10.1093/cei/uxad124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Genevieve T Clutton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8 T cells recognize infected and cancerous cells via their T-cell receptor (TCR), which binds peptide–MHC complexes on the target cell. The affinity of the interaction between the TCR and peptide–MHC contributes to the antigen sensitivity, or functional avidity, of the CD8 T cell. In response to peptide–MHC stimulation, the TCR–CD3 complex and CD8 co-receptor are downmodulated. We quantified CD3 and CD8 downmodulation following stimulation of human CD8 T cells with CMV, EBV, and HIV peptides spanning eight MHC restrictions, observing a strong correlation between the levels of CD3 and CD8 downmodulation and functional avidity, regardless of peptide viral origin. In TCR-transduced T cells targeting a tumor-associated antigen, changes in TCR-peptide affinity were sufficient to modify CD3 and CD8 downmodulation. Correlation analysis and generalized linear modeling indicated that CD3 downmodulation was the stronger correlate of avidity. CD3 downmodulation, simply measured using flow cytometry, can be used to identify high-avidity CD8 T cells in a clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesReceptors, Antigen, T-CellHumansDown-RegulationCD8 AntigensPeptidesCD3 Complex

Stichwörter der Autor:innen

CD8 + T cellsT-cell receptorsanti-viral immunityhumantumor immunology

Substanzen

Receptors, Antigen, T-CellCD8 AntigensPeptidesCD3 Complex

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

ORCID-Profile: Genevieve T Clutton

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health
  • University of North Carolina at Chapel Hill Center

Zitieren

APA

Clutton, G. T., Weideman, A. M. K., Mischell, M. A., Kallon, S., Conrad, S. Z., Shaw, F. R., Warren, J. A., Lin, L., Kuruc, J. D., Xu, Y., Gay, C. M., Armistead, P. M., G Hudgens, M., & Goonetilleke, N. P. (2024). CD3 downregulation identifies high-avidity human CD8 T cells. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxad124

Vancouver

Clutton GT, Weideman AMK, Mischell MA, Kallon S, Conrad SZ, Shaw FR, et al. CD3 downregulation identifies high-avidity human CD8 T cells. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxad124

BibTeX
@article{Clutton2024,
  author = {Clutton, Genevieve T and Weideman, Ann Marie K and Mischell, Melissa A and Kallon, Sallay and Conrad, Shayla Z and Shaw, Fiona R and Warren, Joanna A and Lin, Lin and Kuruc, JoAnn D and Xu, Yinyan and Gay, Cynthia M and Armistead, Paul M and G Hudgens, Michael and Goonetilleke, Nilu P},
  title = {CD3 downregulation identifies high-avidity human CD8 T cells},
  journal = {Clinical and Experimental Immunology},
  year = {2024},
  doi = {10.1093/cei/uxad124}
}
Kostenlos starten →